Somatic mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2) were detected in approximately 80 % of diffuse and anaplastic astrocytomas as well as secondary GBMs. This evidence concerns the gene IDH1 and anaplastic astrocytoma.